Comparative Analysis between Two Anticancer Drugs: Platinum Complexes and Camptothecin in Ovarian Cancer Treatment
Ovarian cancer (OC) has a high mortality rate for women. Except for those screening tools that help discover tumour cells, chemotherapy plays an indispensable role in treating ovarian cancer. Nowadays, an increasing number of anticancer drugs are developed, including synthetic and naturally extracte...
Saved in:
| Main Author: | Zhou Yuhan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
EDP Sciences
2025-01-01
|
| Series: | MATEC Web of Conferences |
| Online Access: | https://www.matec-conferences.org/articles/matecconf/pdf/2025/04/matecconf_menec2025_03016.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synergistic anticancer effects of camptothecin and sotorasib in KRAS-mutated pancreatic ductal adenocarcinoma
by: Prasanna Srinivasan Ramalingam, et al.
Published: (2025-07-01) -
ERCC1 as a Marker of Ovarian Cancer Resistance to Platinum Drugs
by: T. A. Bogush, et al.
Published: (2020-05-01) -
The leadership of topotecan in the treatment of recurrent platinum-resistant ovarian cancer
by: K. E. Borisov
Published: (2014-07-01) -
Redox-sensitive camptothecin prodrug: A promising drug delivery strategy with ultrahigh drug loading and tunable drug release
by: Shiwei Fu, et al.
Published: (2025-12-01) -
Design, Synthesis, and Evaluation of Camptothecin-Based Antibody–Drug Conjugates with High Hydrophilicity and Structural Stability
by: Tingyu Xiong, et al.
Published: (2025-03-01)